STOCKSCREENR
Log In

BFRI

NASDAQ

Biofrontera Inc.

$0.89+0.00(+0.01%)Mkt Cap: $10.36M

Key Stats

Market Cap

$10.36M

P/E Ratio

-0.59

EPS

$-1.50

Dividend Yield

0.00%

52-Week Range

$0.54 — $1.19

Volume

25.91K

Avg Volume

479.41K

Beta

0.63

Valuation

P/E (TTM)

-0.59

Forward P/E

—

PEG Ratio

-0.01

P/S (TTM)

0.27

P/B (TTM)

-3.63

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

29.95%

ROA (TTM)

-1.14%

ROIC

—

Gross Margin

0.66%

Operating Margin

-0.47%

Net Margin

—

Debt/Equity

-1.90

Current Ratio

1.15

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-6.20%

EPS Growth (5Y)

-4.00%

Sales Growth (3Y)

+0.16%

Sales Growth (5Y)

+0.09%

EPS Est (This Year)

$-0.09

EPS Est (Next Year)

$0.14

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.32

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

11.65M

Float

9.95M

Free Float %

85.40%

About

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

US

Exchange

NASDAQ

IPO Date

2021-10-29

Employees

92

CEO

Hermann Luebbert

Index Membership

—

Website

https://www.biofrontera.us.com

Biofrontera Inc. (BFRI) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NASDAQ. With a market capitalization of $10.36M, a P/E ratio of -0.59, BFRI is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare BFRI against other stocks using dozens of fundamental and technical filters.

Similar Stocks

DHB.V

Delivra Health Brands Inc.

$0.19

+0.00%

$5.94M

ROMJ.V

Rubicon Organics Inc.

$0.51

+4.08%

$34.26M

HASH.V

Simply Solventless Concentrates

$0.06

+37.50%

$6.35M

PCLO.V

PharmaCielo Ltd.

$0.07

+7.69%

$13.16M

SNOA

Sonoma Pharmaceuticals, Inc.

$2.40

+0.00%

$4.15M

CPIX

Cumberland Pharmaceuticals Inc.

$3.01

-1.63%

$45.02M

Frequently Asked Questions

What is Biofrontera Inc.'s P/E ratio?

Biofrontera Inc. (BFRI) has a trailing twelve-month (TTM) P/E ratio of -0.59. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Biofrontera Inc. pay a dividend?

No, Biofrontera Inc. (BFRI) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Biofrontera Inc.'s market cap?

Biofrontera Inc. (BFRI) has a market capitalization of $10.36 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.